Accessibility Menu
 

Scienture

(NASDAQ) SCNX

Current Price$0.47
Market Cap$19.50M
Since IPO (2024)-96%
5 Year-99%
1 Year-72%
1 Month+19%

Scienture Financials at a Glance

Market Cap

$19.50M

Revenue (TTM)

$653.39K

Net Income (TTM)

$20.55M

EPS (TTM)

$-1.81

P/E Ratio

-0.27

Dividend

$0.00

Beta (Volatility)

0.98 (Low)

Price

$0.47

Volume

226,876.433

Open

$0.46

Previous Close

$0.48

Daily Range

$0.45 - $0.47

52-Week Range

$0.37 - $2.60

SCNX News

No articles available.

SCNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scienture

Industry

Health Care Technology

Employees

19

CEO

Shankar Hariharan, PhD; Narasimhan Mani, PhD, MBA

Headquarters

Tampa, FL 33634, US

SCNX Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

-25%

Net Income Margin

-31%

Return on Equity

-24%

Return on Capital

-17%

Return on Assets

-20%

Earnings Yield

-3.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$19.50M

Shares Outstanding

40.63M

Volume

226.88K

Short Interest

0.00%

Avg. Volume

3.35M

Financials (TTM)

Gross Profit

$6.00K

Operating Income

$14.70M

EBITDA

$17.39M

Operating Cash Flow

$14.27M

Capital Expenditure

$12.00K

Free Cash Flow

$14.28M

Cash & ST Invst.

$308.10K

Total Debt

$3.53M

Scienture Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$590.05K

+809.7%

Gross Profit

$574.62K

+14698.4%

Gross Margin

97.39%

N/A

Market Cap

$19.50M

N/A

Market Cap/Employee

$1.39M

N/A

Employees

14

N/A

Net Income

$3.61M

-13.3%

EBITDA

$1.80M

+39.0%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.20M

-1.1%

Accounts Receivable

$652.55K

-88.8%

Inventory

$234.52K

+2874.6%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$2.56M

+684.1%

Return on Assets

-19.61%

N/A

Return on Invested Capital

-16.98%

N/A

Free Cash Flow

$3.21M

+40.5%

Operating Cash Flow

$3.21M

+40.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AEONAEON Biopharma, Inc.
$1.11+3.74%
TRAWTraws Pharma, Inc.
$2.16+0.93%
BOLTBolt Biotherapeutics, Inc.
$4.57-3.99%
EVGNEvogene Ltd.
$0.90+6.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.56+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.83+0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.52-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.56-0.03%

Questions About SCNX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.